The Baron Durable Advantage Fund increased its position in Danaher Corporation (DHR) despite the company facing cyclical challenges in the life science tools sector, such as constrained biotechnology funding, reduced NIH funding, and pricing pressures in China. The fund sees long-term value in Danaher, a healthcare and life science tools company, focusing on its strong competitive advantages and consistent shareholder returns, while acknowledging current headwinds. Danaher’s stock closed at $219.98 on February 11, 2026, with a market capitalization of $155.504 billion, and was held by 117 hedge funds at the end of Q3 2025.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Baron Durable Advantage Fund Bets on Danaher Corporation (DHR) During Cyclical Challenges
The Baron Durable Advantage Fund increased its position in Danaher Corporation (DHR) despite the company facing cyclical challenges in the life science tools sector, such as constrained biotechnology funding, reduced NIH funding, and pricing pressures in China. The fund sees long-term value in Danaher, a healthcare and life science tools company, focusing on its strong competitive advantages and consistent shareholder returns, while acknowledging current headwinds. Danaher’s stock closed at $219.98 on February 11, 2026, with a market capitalization of $155.504 billion, and was held by 117 hedge funds at the end of Q3 2025.